Cure Model for End-Stage Chronic Kidney Disease Patients at Benjamin Mkapa Hospital, Dodoma,Tanzania

This research intended to fit the cure model for end-stage chronic kidney disease (CKD) patients by using statistical computing methods, comparing the survival probabilities of CKD treatments and determining the influence of treatments’ sponsorship on the survival of CKD patients. The study used a dataset from Benjamin Mkapa Hospital (BMH) of end-stage CKD patients treated from 2018 to 2021 for a follow-up time of 172 weeks and an exponentiated half-logistic (EHLD) distribution used as baseline distribution in this cure model. The findings revealed that the cure probability for National health insurance fund (NHIF) sponsored patients were 46% and the cure probability for self-sponsored patients was 5%. Additionally, the median survival for NHIF-sponsored subjects was 48 weeks and for self-sponsored was 36 weeks. The cure fraction for NHIF-sponsored CKD patients was significantly higher than for self-sponsored patients. Therefore, treatment sponsorship was a significant factor in the survival of end-stage CKD patients. This is a call to government institutions and various health stakeholders to improve CKD awareness among Tanzanians and access to CKD treatments.